ReWalk Robotics’ (LFWD) “Buy” Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of ReWalk Robotics (NASDAQ:LFWD – Free Report) in a report released on Monday, Benzinga reports. HC Wainwright currently has a $9.00 price target on the stock.

ReWalk Robotics Stock Performance

Shares of NASDAQ LFWD opened at $5.00 on Monday. The firm has a market capitalization of $42.50 million, a P/E ratio of -1.74 and a beta of 2.00. The business has a 50-day simple moving average of $5.64. ReWalk Robotics has a fifty-two week low of $3.90 and a fifty-two week high of $9.10.

ReWalk Robotics (NASDAQ:LFWD – Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The company reported ($0.35) earnings per share for the quarter, topping the consensus estimate of ($0.91) by $0.56. The business had revenue of $6.88 million during the quarter, compared to the consensus estimate of $7.20 million. ReWalk Robotics had a negative return on equity of 28.19% and a negative net margin of 159.76%. On average, analysts expect that ReWalk Robotics will post -1.82 EPS for the current year.

About ReWalk Robotics

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.

Read More

Receive News & Ratings for ReWalk Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ReWalk Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.